EP0039369B1 — Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
Assigned to Merck Sharp and Dohme LLC · Expires 1983-06-15 · 43y expired
What this patent protects
The present invention relates to novel solvates of beclomethasone dipropionate with alkanes, especially n-alkanes, having from 5 to 8 carbon atoms, and to their preparation, e.g. by contacting beclomethasone d propionate with the alkane. The novel solvates can be used in inhalati…
USPTO Abstract
The present invention relates to novel solvates of beclomethasone dipropionate with alkanes, especially n-alkanes, having from 5 to 8 carbon atoms, and to their preparation, e.g. by contacting beclomethasone d propionate with the alkane. The novel solvates can be used in inhalation devices and in the preparation of beclomethasone dipropionate-trichlorofluoromethane solvate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.